Magic Lifescience Analysis: $164K Raised
What is Magic Lifescience?
Magic Lifescience develops the MagChipR™ Point-of-Care Lab-on-Chip Molecular Diagnostic Analyzer, which provides rapid results for infectious diseases and antimicrobial resistance in under 20 minutes. The technology utilizes ultra-fast PCR and DNA detection on a GMR biosensor chip, enabling simultaneous identification of pathogens and their resistance profiles.
Location
319 N Bernardo Ave, Mountain View, California 94043, United States
Employees
11-50
Founded
2021
Funding Status
Not Funded
Product Features & Capabilities
- MagChipR™ POC LOC MDx Analyzer
- MagChip™ STI
- MagChip Menu
Use Cases
Identify infectious pathogens in under 20 minutes; Determine antimicrobial susceptibility profiles for effective treatment; Conduct rapid diagnostics in clinical settings; Enable in-house testing without reliance on microbiology labs; Support healthcare providers with near-patient testing capabilities
Other Considerations
Product in development, not FDA cleared; First-of-its-kind technology in molecular diagnostics; Focus on rapid, accurate results for infectious diseases
See something that needs updating? Suggest edits to this profile.